The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers

OBJECTIVES: Comparative data on hydroxychloroquine and favipiravir, commonly used agents in the treatment of Coronavirus Disease-2019 (COVID-19), are still limited. In this study, it was aimed to compare treatment outcomes in healthcare workers with COVID-19 who were prospectively followed by the oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Turan, Derya Bayırlı, Menteş, Mehtap, Özel, Yıldıran, Şerefhanoğlu, Kıvanç, Aydoğan, Burcu, İbil, Neşe, Güneşdoğdu, Füsun, Orucova, Hijran Mammadova, Saltürk, Cüneyt, Çelik, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806128/
https://www.ncbi.nlm.nih.gov/pubmed/35139366
http://dx.doi.org/10.1016/j.bjid.2022.102328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806128/
https://www.ncbi.nlm.nih.gov/pubmed/35139366
http://dx.doi.org/10.1016/j.bjid.2022.102328

Ejemplares similares